Lexaria Bioscience (LEXX) Gains from Investment Securities (2016 - 2025)
Historic Gains from Investment Securities for Lexaria Bioscience (LEXX) over the last 12 years, with Q4 2025 value amounting to $7331.0.
- Lexaria Bioscience's Gains from Investment Securities rose 752.42% to $7331.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $28540.0, marking a year-over-year decrease of 8120.59%. This contributed to the annual value of $586500.0 for FY2025, which is 1579.33% down from last year.
- According to the latest figures from Q4 2025, Lexaria Bioscience's Gains from Investment Securities is $7331.0, which was up 752.42% from $7199.0 recorded in Q3 2025.
- Lexaria Bioscience's Gains from Investment Securities' 5-year high stood at $834936.0 during Q2 2024, with a 5-year trough of $6818.0 in Q4 2024.
- In the last 5 years, Lexaria Bioscience's Gains from Investment Securities had a median value of $11204.0 in 2022 and averaged $149372.9.
- Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 413452.34% in 2023, then tumbled by 9915.33% in 2025.
- Lexaria Bioscience's Gains from Investment Securities (Quarter) stood at $10987.0 in 2021, then skyrocketed by 305.93% to $44600.0 in 2022, then plummeted by 75.6% to $10881.0 in 2023, then crashed by 37.34% to $6818.0 in 2024, then grew by 7.52% to $7331.0 in 2025.
- Its last three reported values are $7331.0 in Q4 2025, $7199.0 for Q3 2025, and $7069.0 during Q2 2025.